Loss of STIM2 in colorectal cancer drives growth and metastasis through metabolic reprogramming and PERK-ATF4 endoplasmic reticulum stress pathway.
Trayambak PathakJ Cory BensonMartin T JohnsonPing XinAhmed Emam AbdelnabyVonn WalterWalter A KoltunGregory S YochumNadine HempelMohamed TrebakPublished in: bioRxiv : the preprint server for biology (2023)
and is associated with poor patient prognosis. STIM2 downregulation induces PERK/ATF4 dependent ER stress in colorectal cancer.Increased ER stress drives colorectal cancer metabolic reprogramming, growth, and metastasis.